AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.100
+0.040 (1.94%)
At close: May 13, 2025, 4:00 PM
2.070
-0.030 (-1.43%)
Pre-market: May 14, 2025, 6:24 AM EDT

AbCellera Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Cash & Equivalents
159.27156.33133.32386.54476.14594.12
Upgrade
Short-Term Investments
446469.29627.27499.95246.84-
Upgrade
Cash & Short-Term Investments
605.27625.61760.59886.49722.98594.12
Upgrade
Cash Growth
-13.29%-17.75%-14.20%22.62%21.69%7765.96%
Upgrade
Accounts Receivable
40.0133.6230.5938.59160.58213.24
Upgrade
Other Receivables
-26.5333.7964.8214.280.49
Upgrade
Receivables
40.0192.1364.38103.41174.86213.73
Upgrade
Inventory
---1.531.671.41
Upgrade
Prepaid Expenses
-8.6322.029.065.294.07
Upgrade
Restricted Cash
2525252525-
Upgrade
Total Current Assets
764.98751.37871.991,025929.8813.33
Upgrade
Property, Plant & Equipment
347.1340.43287.7217.26111.6217.92
Upgrade
Long-Term Investments
81.5782.365.9434.4232.3120.03
Upgrade
Goodwill
47.8147.8147.8147.8147.8131.5
Upgrade
Other Intangible Assets
41.1942.11120.43131.5148.39115.15
Upgrade
Long-Term Deferred Tax Assets
-----5.9
Upgrade
Other Long-Term Assets
61.5666.9480.3440.8330.641.71
Upgrade
Total Assets
1,3441,3611,4881,5411,3191,006
Upgrade
Accounts Payable
47.8434.3528.614.8314.927.32
Upgrade
Accrued Expenses
-8.387.7125.826.5429.13
Upgrade
Current Portion of Leases
-4.626.165.583.650.68
Upgrade
Current Income Taxes Payable
----35.6836.15
Upgrade
Current Unearned Revenue
18.7921.1826.0727.912.017.53
Upgrade
Other Current Liabilities
8.778.0950.4844.2127.8722.68
Upgrade
Total Current Liabilities
75.476.61119.01118.32120.68103.49
Upgrade
Long-Term Leases
63.2160.7471.2276.6836.413.72
Upgrade
Long-Term Unearned Revenue
170.94155.59104.1160.3260.7625.89
Upgrade
Long-Term Deferred Tax Liabilities
10.0510.0530.6133.1837.3726.16
Upgrade
Other Long-Term Liabilities
1.621.4710.8219.1437.6215.77
Upgrade
Total Liabilities
321.23304.47335.78307.63292.84175.03
Upgrade
Common Stock
790.07777.17753.2734.37722.43710.39
Upgrade
Additional Paid-In Capital
168.6166.36121.0574.1235.365.92
Upgrade
Retained Earnings
71.31116.93279.79426.19267.67114.2
Upgrade
Comprehensive Income & Other
-7-4.38-1.72-1.390.28-
Upgrade
Total Common Equity
1,0231,0561,1521,2331,026830.51
Upgrade
Shareholders' Equity
1,0231,0561,1521,2331,026830.51
Upgrade
Total Liabilities & Equity
1,3441,3611,4881,5411,3191,006
Upgrade
Total Debt
63.2165.3677.3882.2640.074.39
Upgrade
Net Cash (Debt)
542.06560.25683.21804.23682.91589.73
Upgrade
Net Cash Growth
-13.19%-18.00%-15.05%17.76%15.80%88982.48%
Upgrade
Net Cash Per Share
1.831.902.362.552.152.24
Upgrade
Filing Date Shares Outstanding
297.69297.99292.78287.69283.92269.5
Upgrade
Total Common Shares Outstanding
297.69295.76290.82286.85283.26269.5
Upgrade
Working Capital
689.58674.76752.97907.17809.12709.84
Upgrade
Book Value Per Share
3.443.573.964.303.623.08
Upgrade
Tangible Book Value
933.98966.17984.091,054829.54683.86
Upgrade
Tangible Book Value Per Share
3.143.273.383.672.932.54
Upgrade
Land
-53.4153.4153.4133.04-
Upgrade
Buildings
-52.9143.9511.361.21-
Upgrade
Machinery
-84.2973.8749.5626.6515.87
Upgrade
Leasehold Improvements
-122.8973.9440.5722.753.71
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q